LifeVantage (LFVN) Competitors

Sionna Therapeutics (NASDAQ:SION) and LifeVantage (NASDAQ:LFVN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends, analyst recommendations and community ranking.

Does the MarketBeat Community favor SION or LFVN?

LifeVantage received 220 more outperform votes than Sionna Therapeutics when rated by MarketBeat users. Likewise, 77.97% of users gave LifeVantage an outperform vote while only 75.00% of users gave Sionna Therapeutics an outperform vote.

Company	Underperform	Outperform
Sionna Therapeutics	Outperform Votes 3 75.00%	Underperform Votes 1 25.00%
LifeVantage	Outperform Votes 223 77.97%	Underperform Votes 63 22.03%

Do institutionals and insiders believe in SION or LFVN?

35.3% of LifeVantage shares are owned by institutional investors. 3.9% of Sionna Therapeutics shares are owned by insiders. Comparatively, 20.7% of LifeVantage shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Is SION or LFVN more profitable?

LifeVantage has a net margin of 3.46% compared to Sionna Therapeutics' net margin of 0.00%. LifeVantage's return on equity of 34.29% beat Sionna Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sionna Therapeutics	N/A	N/A	N/A
LifeVantage	3.46%	34.29%	15.04%

Do analysts rate SION or LFVN?

Sionna Therapeutics currently has a consensus price target of $38.50, suggesting a potential upside of 126.60%. LifeVantage has a consensus price target of $30.50, suggesting a potential upside of 136.99%. Given LifeVantage's higher probable upside, analysts clearly believe LifeVantage is more favorable than Sionna Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sionna Therapeutics	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
LifeVantage	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media prefer SION or LFVN?

In the previous week, Sionna Therapeutics had 3 more articles in the media than LifeVantage. MarketBeat recorded 7 mentions for Sionna Therapeutics and 4 mentions for LifeVantage. LifeVantage's average media sentiment score of 1.30 beat Sionna Therapeutics' score of 0.74 indicating that LifeVantage is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sionna Therapeutics	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LifeVantage	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher valuation & earnings, SION or LFVN?

LifeVantage has higher revenue and earnings than Sionna Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sionna Therapeutics	N/A	N/A	N/A	N/A	N/A
LifeVantage	$222.35M	0.73	$2.94M	$0.69	18.65

Summary

LifeVantage beats Sionna Therapeutics on 10 of the 12 factors compared between the two stocks.